Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial

INTRODUCTION: Retinopathy of prematurity (ROP) is a disease observed in extremely premature infants characterised by visioning-threatening retinal vessel proliferation. Propranolol, a drug used for decades in newborn infants with heart diseases, hypertension and thyrotoxicosis and licenced for infan...

Descripción completa

Detalles Bibliográficos
Autores principales: Bührer, Christoph, Erdeve, Ömer, Bassler, Dirk, Bar-Oz, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042594/
https://www.ncbi.nlm.nih.gov/pubmed/29982217
http://dx.doi.org/10.1136/bmjopen-2018-021749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042594/
https://www.ncbi.nlm.nih.gov/pubmed/29982217
http://dx.doi.org/10.1136/bmjopen-2018-021749

Ejemplares similares